Dr. Fernando Torres, MD

Dr. Torres practices at William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System.

Dr. Torres' NPI, 1205856366, was assigned on July 20, 2006. Dr. Torres graduated from Weill Cornell Medicine in 1994. Dr. Torres holds Texas license J8804.

Dr. Torres' primary practice is William P. Clements Jr. University Hospital, at 6201 Harry Hines Blvd, Dallas, TX 75390 in Dallas County. The practice phone is (214) 633-5555.

Dr. Torres' primary practice is William P. Clements Jr. University Hospital in Dallas, Texas, part of The University of Texas System. Dr. Torres is also affiliated with Covenant Medical Center. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Torres to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Torres practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Torres' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Torres is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Torres' licenses on file in 2 states: Texas and Colorado.

Dmand AI lists acute respiratory failure, chronic lung disease, pneumonia, pneumonia and respiratory infection and pulmonary heart disease among the conditions Dr. Torres treats.

CMS data shows 1,015 Medicare services from Dr. Torres across 12 procedure codes in 2024, for 201 Medicare patients. Medicare paid $68,716 for them.

CMS counts 201 Medicare patients who saw Dr. Torres in 2024. The largest group is 65 to 74, with 113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Torres' median patient age at 66, with 47% women.

In 2024, Dr. Torres wrote 2,596 Medicare Part D claims for 313 patients. 93% of them were for generic drugs. CMS names the drug for 2,138 of them, across 49 drugs with 11 or more claims each, at $666,403 in total drug cost. In 2023, CMS named 2,549 claims across 65 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Torres for performance year 2024, reported as part of a group. Dr. Torres accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Torres as offering telehealth.

Dmand AI links 23 papers to Dr. Torres, published from 2016 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Lung Transplantation, COVID-19 and SARS-CoV-2. Dr. Torres has published most often in Clin Transplant. Dr. Torres' most frequent co-authors are Vaidehi Kaza, MD, MPH, Srinivas Bollineni, MD and Manish R. Mohanka, MD, MPH.

Dmand AI links Dr. Torres to 4 clinical trials, 3 of them phase 2 studies. Conditions studied include Pulmonary Arterial Hypertension, Hypertension, Pulmonary and Cryptogenic Organizing Pneumonia. University of Texas Southwestern Medical Center sponsors the most, 2.

CMS Open Payments shows 547 general payments to Dr. Torres from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 58% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $213,144. It also lists 5 research payments totaling $6,382 in 2017.

Dmand AI lists 1 award for Dr. Torres, most recently CMS Stage 1 EHR in 2012.

Dr. Torres graduated from Weill Cornell Medicine in 1994.

Dr. Torres is in network with 23 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.